Interferons: Current status and future directions of this prototypic biological
- 1 May 1986
- journal article
- clinical trial
- Published by Springer Nature in Springer Seminars in Immunopathology
- Vol. 9 (1) , 73-83
- https://doi.org/10.1007/bf00201906
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Biological response modifiers: Preclinical evaluation and clinical activityCritical Reviews in Oncology/Hematology, 1984
- Phase II study of recombinant leukocyte a interferon (rIFN-αA) in disseminated malignant melanomaCancer, 1984
- In vitro and in vivo studies on potentiation of cytotoxic effects of anticancer drugs or cobalt 60 gamma ray by interferon on human neoplastic cellsCancer, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983
- Interferon potentiates cytotoxic effects of 5-fluorouracil on cell proliferation of established human cell lines originating from neoplastic tissuesCancer Letters, 1983
- Administration of fibroblast interferon to patients with advanced breast cancer: Possible effects on skin metastasis and on hormone receptorsEuropean Journal of Cancer and Clinical Oncology, 1982
- Human leukocyte interferon produced by E. coli is biologically activeNature, 1980
- Human lymphoblastoid interferon can inhibit the growth of human breast cancer xenografts in athymic (nude) micePublished by Elsevier ,1980
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979